Skip to main content

Table 2 Summary of FG measures in different groups

From: Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort

Trait

Group

Number of subjects

Number of FG measures

FG level (median mg/dl ± IQR)

Age at time of FG measure (median ± IQR)

Sex

All

87,151

593,130

97 ± 16

64.5 ± 15.9

Female

51,481

325,084

95 ± 14

63.6 ± 16.3

Male

35,670

268,046

99 ± 18

65.4 ± 15.3

Age

[21,40]

8294

16,811

90 ± 12

35.8 ± 6.2

(40,50]

23,247

53,946

93 ± 13

46.4 ± 4.6

(50,60]

44,328

139,694

96 ± 16

55.8 ± 4.8

(60,70]

49,487

196,287

98 ± 16

65.1 ± 4.9

(70,80]

32,416

140,695

99 ± 16

74.2 ± 4.8

(80,90]

12,012

45,697

99 ± 17

83.1 ± 3.9

Race/ethnicity

African American

2693

18,511

97 ± 21

61.7 ± 15.7

East Asian

6404

47,561

98 ± 17

60.9 ± 16.8

Latino

Hispanic

7225

47,719

98 ± 18

60.6 ± 17.5

South Asian

400

3017

99 ± 21

57.3 ± 18

White

70,429

476,322

97 ± 16

65.3 ± 15.4

Statin user

Never

44,473

245,340

94 ± 12

61.5 ± 17.6

Before

39,552

160,055

98 ± 17

63.0 ± 13.9

During

35,332

187,735

101 ± 22

68.9 ± 13.9